BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Press Releases

October 16, 2014BIO-Europe® 2014 Program is abundant showcase of life science pharma executives and thought leaders BIO-Europe® 2014 international partnering conference will take place, November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging...  more ►

October 8, 2014BIO-Europe® 2014 partnering meetings expected to surpass all previous events The BIO-Europe® 2014 international partnering conference will take place in one month on November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt. BIO-Europe is the largest dedicated partnering conference worldwide serving the life science industry. The 2014 Frankfurt event projects the number of one-to-one partnering meetings to surpass the 2013 all-time rec...  more ►

August 12, 2014BIO-Europe® 2014 kicks off its 20th year as life science partnering leader
Event will be held in Frankfurt, Germany this year
The twentieth annual BIO-Europe® international partnering conference will take place November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. "BIO-Europe has continued to be the leading European life science partnering event because of the high caliber companies that bring their teams to partner," said Florian Schoenhammer, Managing Direct...  more ►

August 1, 2014Spotlight on Frankfurt Business Facts The state of Hessen has top ranked cities: Frankfurt, Wiesbaden and Kassel are among the top 10 cities in Germany (based on WiWo City Ranking 2012). Frankfurt is Germany's major airport and leading hub in Europe with over 57.5 million passengers per year and 4,575 direct flight connections per week. Overall, 108 airlines fly to 295 destinations in 105 countries. There are tw...  more ►


partnering360® Blog

October 21, 2014 News from around BIO-Europe® With BIO-Europe just weeks away, many companies are have moved various products along the pipeline and many are seeing success in developing and moving drugs through pipelines: - Apricus Biosciences recently announced that Notice of Allowance for they have received U.S. Patent Application Serial... more ►

October 17, 2014 MediSapiens and Mediconomics look to collaboration for growth To gear up for BIO-Europe®, our team at Insight has spoken with some of the companies coming to the event early next month to see what they’re doing and who they’re looking to meet with at the event. Experimental Therapeutics Centre (ETC), one of a few fully integrated drug discovery... more ►

October 16, 2014 Outtakes from the Stem Cell Meeting on the Mesa 2014 plenary The recent Stem Cell Meeting on the Mesa 2014 opened with a timely plenary session entitled “Cell Therapy Product Development: Maintaining Momentum in the Face of Expected Clinical Challenges.” The panel was chaired by Mark Stevenson, EVP & President, Life Science Solutions, Life... more ►

October 10, 2014 Charleston Laboratories drive for pain management therapeutics Charleston Laboratories, Inc., one of the companies that will be joining us in Frankfurt as a participating company. recently shared their unique startup story with AL.com.  Their road to a successful specialty pharma company has taken a unique path. Two university classmates turned business... more ►

October 7, 2014 Tips for preparing for BIO-Europe® Guest post contributed by Carlos N. Velez, Ph.D., Managing Partner, Lacerta Bio Inc. In a few short weeks, over 3,000 of us will descend onto Frankfurt, Germany for the 20th Anniversary edition of the BIO-Europe® conference. For many of us, our objective is to meet prospective partners, clients, or... more ►



partnering360:Insight Latest headlines from partnering360:Insight

October 20, 2014 Merck Serono: FIT for partnering and playing with the home court advantage "We are interested in opportunities—spanning from promising drug candidates up to technology platforms—that will support our strategic business objectives, and strengthen our pipeline, our key franchises, and our geographic presence." more ►

October 17, 2014 Antigen Express advances immunotherapy Antigen Express is developing a novel way to boost the immune system, developing a therapeutic platform that can produce off-the-shelf, synthetic peptide vaccines for major diseases, including cancer, HIV, influenza, diabetes and, potentially, Ebola. more ►

October 17, 2014 Third Rock Ventures sees “renaissance of innovation in life sciences” A co-founder of Third Rock Ventures, Kevin Starr focuses on the development and business strategy of the portfolio companies, actively identifying and evaluating new investments. In March, 2013 the firm raised USD 516 million for its Fund III. Several new companies have since been launched and Starr said a further 14 companies will be formed, "most of which are already under consideration inside Third Rock, though we have not announced anything to the outside world yet." more ►

October 13, 2014 Accelerating drug discovery in Singapore creates global successes Building on a string of recent successes, a team from Singapore's Experimental Therapeutics Centre (ETC) arrives in Frankfurt for BIO-Europe® 2014 looking for new opportunities in early stage co-discovery projects. more ►

October 11, 2014 Customized bio-IT solutions are not just for big pharma anymore BIO-Europe® 2014 in Frankfurt will see the soft launch for a bundled product-and-service called the MediSapiens Explorer Platform that brings to small and medium-sized biotechs and pharma companies a platform for managing and accessing massive data sets, and the tools to visualize it in scientist-friendly way. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe EBD Group BIO BIO-Europe